Luis De Jesus writes about how Cuba plans to take on 2021, looking closely at the new ambitious economic development strategy “the Ordering Task”

The global response to the COVID-19 pandemic in terms of developing a vaccine has been unprecedented. However, there is still a lot to be understood about the disease and the virus which causes

Immunologist Dr. Satyajit Rath talks about reports of a strain of COVID-19 from the UK, the transmission rate and its implications on public health policy

The novel coronavirus can integrate its genetic material or RNA into human chromosome and reproduce itself, the study suggests

As trials for vaccine candidates continue, the question of which countries will gain access to it has become pressing. Low-income countries are likely to suffer in this regard

Are asymptomatic people the real drivers of COVID-19 progression? Researchers are divided as more studies arrive that further complicate the question

The study analyzed the immune memory against the virus in 185 patients who had recovered from COVID-19. These included patients who were asymptomatic and those who exhibited severe clinical symptoms

There is not enough data to conclusively predict if the onset of winter will lead to a greater spread of the infection. However, researchers have been studying the possibility through a variety of ways

None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir

Contrary to the Narendra Modi government’s claims, India’s low case fatality rate in the COVID-19 pandemic is not because of any well-thought out strategy. It is rather due to a relatively young population and some statistical tricks

Dr. Satyajit Rath talks about the immunity developed in recovered COVID-19 patients and also the immunity that the potential vaccines can induce.

Candidate vaccines which have shown promising results have all reported trying to elicit a T cell immune response along with antibody production